サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1425852

STD診断の世界市場レポート2024

STD Diagnostics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
STD診断の世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

STD診断の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.8%の年間複合成長率（CAGR）で148億2,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化医療動向の出現、ヘルスケアアクセスの強化、国民健康戦略の実施、遠隔医療とデジタル医療ソリューションの統合、性感染症の発生率の増加など、さまざまな要因に関連している可能性があります。この期間に予想される注目すべき動向には、POCT（Point-of-Care Testing）の進歩、家庭用検査キットの利用可能性、マルチプレックス検査法の開発、ターゲットを絞ったマーケティングとアウトリーチ活動、曝露前予防薬（PrEP）プログラムの確立、罹患率の継続的な上昇などが含まれます。

性感染症（STD）の蔓延は、STD診断市場を前進させる重要な原動力となっています。 STD（性的接触によって伝染する感染症）は、世界の健康上の懸念となっています。 2022年、世界保健機関は、世界中で毎日100万件を超える性感染症が発生しており、クラミジア、淋病、梅毒、トリコモナス症を含む年間約3億7,400万件の新たな感染症が発生していると報告しました。 STDの発生率の上昇は、市場の成長を促進する効率的な分析と検査におけるSTD診断の重要な役割を強調しています。

予想されるヘルスケア支出の増加は、STD診断市場の成長をさらに促進すると予想されます。特定のヘルスケア制度または経済内でのヘルスケアサービスおよび関連活動に費やされる総額を表すヘルスケア支出は、予防ヘルスケアへの戦略的投資です。それは公衆衛生の優先事項に取り組み、全体的な健康と幸福に貢献します。英国国家統計局の報告書によると、2023年5月の時点で、2020年から2021年にかけてヘルスケア支出が9.4%増加し、3,672億5,000万米ドル（2,807億ポンド）に達したことが明らかになった。これには、医薬品支出の大幅な増加が含まれており、2021年には518億4,000万米ドル（396億ポンド）に達し、ヘルスケア医療への支出は2倍以上の459億3,000万米ドル（351億ポンド）に達しました。医療費の大幅な増加は、診断能力の強化を通じてSTDに対処することの重要性の高まりを強調し、STD診断市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のSTD診断市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • クラミジア検査
  • 梅毒検査
  • 淋病検査
  • 単純ヘルペスウイルス検査
  • ヒトパピローマウイルス検査
  • ヒト免疫不全ウイルス検査
  • 下疳検査
  • その他のタイプ
  • 世界のSTD診断市場、検査場所別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 臨床検査
  • ポイントオブケア（PoC）検査
  • 世界のSTD診断市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院と診療所
  • 診断センター
  • 在宅ケア

第7章 地域および国の分析

  • 世界のSTD診断市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のSTD診断市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • STD診断市場の競合情勢
  • STD診断市場の企業プロファイル
    • Siemens AG
    • Abbott Laboratories
    • Qiagen Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r13083

STD Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing; Other Types
  • 2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
  • 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
  • Companies Mentioned: Siemens AG; Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

The STD diagnostics market research report is one of a series of new reports from The Business Research Company that provides STD diagnostics market statistics, including STD diagnostics industry global market size, regional shares, competitors with a STD diagnostics market share, detailed STD diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the STD diagnostics industry. This STD diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The std diagnostics market size has grown rapidly in recent years. It will grow from $9.25 billion in 2023 to $10.19 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The expansion observed during the historical period can be credited to several factors, including epidemiological patterns, advancements in healthcare infrastructure, progress in pharmaceuticals, implementation of sexual education initiatives, and demographic changes.

The std diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. During the forecast period, the anticipated growth can be linked to various factors such as the emergence of personalized medicine trends, enhancements in healthcare access, the implementation of population health strategies, the integration of telemedicine and digital health solutions, and the increasing incidence of STDs. Notable trends expected in this period encompass advancements in point-of-care testing (POCT), the availability of home testing kits, the development of multiplex testing methods, targeted marketing and outreach initiatives, the establishment of pre-exposure prophylaxis (PrEP) programs, and the continual rise in incidence rates.

The escalating prevalence of sexually transmitted diseases (STDs) is a significant driver propelling the STD diagnostics market forward. STDs, infectious diseases transmitted through sexual contact, have become a global health concern. In 2022, the World Health Organization reported that over 1 million sexually transmitted infections are acquired daily worldwide, with approximately 374 million new infections annually, including chlamydia, gonorrhea, syphilis, and trichomoniasis. The rising incidence of STDs underscores the critical role of STD diagnostics in efficient analysis and testing, driving the market's growth.

The anticipated increase in healthcare expenditure is expected to further fuel the growth of the STD diagnostics market. Healthcare expenditure, representing the total amount spent on healthcare services and related activities within a specific healthcare system or economy, is a strategic investment in preventive healthcare. It addresses public health priorities and contributes to overall health and well-being. As of May 2023, a report from the Office for National Statistics in the UK revealed a notable 9.4% increase in healthcare spending between 2020 and 2021, reaching $367.25 billion (£280.7 billion). This included a substantial increase in pharmaceutical expenditure, reaching $51.84 billion (£39.6 billion), and more than doubling spending on preventive care, reaching $45.93 billion (£35.1 billion) in 2021. The significant rise in healthcare expenditures emphasizes the growing importance of addressing STDs through enhanced diagnostic capabilities, thereby driving the STD diagnostics market.

A key trend in the STD diagnostics market is the advancement in diagnostic techniques and facilities. Major players are continually upgrading testing facilities to provide more accurate and rapid diagnoses of sexually transmitted diseases. In May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology company, introduced the BD CORTM MX/PX System, a fully automated, high-throughput infectious disease molecular diagnostics platform. This platform streamlines and automates the molecular laboratory workflow, offering improved efficiency from sample processing to diagnostic test results. The platform's first available test is the BD CTGCTV2 molecular assay, capable of identifying the three most common non-viral sexually transmitted infections such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV). This technological advancement aligns with the broader trend of enhancing diagnostic capabilities within the STD diagnostics market.

Major players in the STD diagnostics market are actively engaged in the development of innovative products to address unmet medical needs and enhance diagnostic capabilities. One such example is the focus on real-time PCR kits, which are collections of reagents utilized for real-time polymerase chain reaction (qPCR), a sensitive and widely used technique for detecting and quantifying specific nucleic acid sequences. In March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit. These kits are specifically designed for the detection of Mycoplasma hominis and Treponema pallidum. Noteworthy features of these kits include high sensitivity and specificity, ease of use, rapid turnaround time, and the ability to detect multiple pathogens in a single test. This innovation contributes to the advancement of diagnostic capabilities in the field of STD diagnostics, providing healthcare professionals with more effective tools for detection and quantification.

In December 2021, Quest Diagnostics, a prominent US-based medical laboratory company, made a strategic move by acquiring Labtech Diagnostics for an undisclosed amount. This acquisition allowed Quest Diagnostics to expand its access to diagnostics innovation and enhance diagnostic services for consumers in South Carolina and the southeast. Labtech Diagnostics, the acquired company, specializes in clinical laboratories and provides diagnostic services for STDs and other infectious diseases. This strategic acquisition aligns with the broader industry trend of major companies actively seeking to broaden their offerings and enhance their diagnostic capabilities within the STD diagnostics market.

Major companies operating in the std diagnostics market report are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., Lybrate Inc., NOWDiagnostics Inc., Alere Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Inflammatix Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. STD Diagnostics Market Characteristics

3. STD Diagnostics Market Trends And Strategies

4. STD Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global STD Diagnostics Market Size and Growth

  • 5.1. Global STD Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global STD Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global STD Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. STD Diagnostics Market Segmentation

  • 6.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Other Types
  • 6.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratory Testing
  • Point Of Care (PoC) Testing
  • 6.3. Global STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Centers
  • Homecare

7. STD Diagnostics Market Regional And Country Analysis

  • 7.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific STD Diagnostics Market

  • 8.1. Asia-Pacific STD Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China STD Diagnostics Market

  • 9.1. China STD Diagnostics Market Overview
  • 9.2. China STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India STD Diagnostics Market

  • 10.1. India STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan STD Diagnostics Market

  • 11.1. Japan STD Diagnostics Market Overview
  • 11.2. Japan STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia STD Diagnostics Market

  • 12.1. Australia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia STD Diagnostics Market

  • 13.1. Indonesia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea STD Diagnostics Market

  • 14.1. South Korea STD Diagnostics Market Overview
  • 14.2. South Korea STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe STD Diagnostics Market

  • 15.1. Western Europe STD Diagnostics Market Overview
  • 15.2. Western Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK STD Diagnostics Market

  • 16.1. UK STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany STD Diagnostics Market

  • 17.1. Germany STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France STD Diagnostics Market

  • 18.1. France STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy STD Diagnostics Market

  • 19.1. Italy STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain STD Diagnostics Market

  • 20.1. Spain STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe STD Diagnostics Market

  • 21.1. Eastern Europe STD Diagnostics Market Overview
  • 21.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia STD Diagnostics Market

  • 22.1. Russia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America STD Diagnostics Market

  • 23.1. North America STD Diagnostics Market Overview
  • 23.2. North America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA STD Diagnostics Market

  • 24.1. USA STD Diagnostics Market Overview
  • 24.2. USA STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada STD Diagnostics Market

  • 25.1. Canada STD Diagnostics Market Overview
  • 25.2. Canada STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America STD Diagnostics Market

  • 26.1. South America STD Diagnostics Market Overview
  • 26.2. South America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil STD Diagnostics Market

  • 27.1. Brazil STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East STD Diagnostics Market

  • 28.1. Middle East STD Diagnostics Market Overview
  • 28.2. Middle East STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa STD Diagnostics Market

  • 29.1. Africa STD Diagnostics Market Overview
  • 29.2. Africa STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. STD Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. STD Diagnostics Market Competitive Landscape
  • 30.2. STD Diagnostics Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Qiagen Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global STD Diagnostics Market Competitive Benchmarking

32. Global STD Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The STD Diagnostics Market

34. STD Diagnostics Market Future Outlook and Potential Analysis

  • 34.1 STD Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 STD Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 STD Diagnostics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer